Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Marek

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Neurology|February 18, 2009
Can we image premotor Parkinson disease?Kenneth Marek, Danna Jennings
Science (New York, N.Y.)|November 1, 2003
Looking backward to move forward: early detection of neurodegenerative disordersSteven T DeKosky, Kenneth Marek
Annals of Neurology|May 7, 2026
Future Directions: The Parkinson's Precision Medicine InitiativeKenneth Marek, Thomas F Tropea
Neurology|September 25, 2003
Imaging the dopamine system to assess disease-modifying drugs: studies comparing dopamine agonists and levodopaKenneth Marek, Danna Jennings, John Seibyl
Advances in Neurology|November 22, 2002
Single-photon emission tomography and dopamine transporter imaging in Parkinson's diseaseKenneth Marek, Danna Jennings, John Seibyl
Annals of Neurology|April 1, 2003
Dopamine agonists and Parkinson's disease progression: what can we learn from neuroimaging studiesKenneth Marek, Danna Jennings, John Seibyl
JAMA Neurology|November 9, 2017
Observations on a 2-Step Approach to Screening for Parkinson Disease-ReplyDanna Jennings, Andrew Siderowf, Kenneth Marek
Seminars in Nuclear Medicine|August 3, 2010
The role of the core imaging laboratory in multicenter trialsJohn Seibyl, Kenneth Marek, I George Zubal
Annals of Neurology|May 5, 2026
From Parkinson's Progression Markers Initiative to Parkinson's Precision Medicine Initiative: Still PPMIKenneth Marek, Sohini Chowdhury, Thomas F Tropea, et al.
Seminars in Nuclear Medicine|October 3, 2012
Neuroimaging over the course of Parkinson's disease: from early detection of the at-risk patient to improving pharmacotherapy of later-stage diseaseJohn Seibyl, David Russell, Danna Jennings, et al.
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Neurology|February 18, 2009
Can we image premotor Parkinson disease?Kenneth Marek, Danna Jennings
Science (New York, N.Y.)|November 1, 2003
Looking backward to move forward: early detection of neurodegenerative disordersSteven T DeKosky, Kenneth Marek
Annals of Neurology|May 7, 2026
Future Directions: The Parkinson's Precision Medicine InitiativeKenneth Marek, Thomas F Tropea
Neurology|September 25, 2003
Imaging the dopamine system to assess disease-modifying drugs: studies comparing dopamine agonists and levodopaKenneth Marek, Danna Jennings, John Seibyl
Advances in Neurology|November 22, 2002
Single-photon emission tomography and dopamine transporter imaging in Parkinson's diseaseKenneth Marek, Danna Jennings, John Seibyl
Annals of Neurology|April 1, 2003
Dopamine agonists and Parkinson's disease progression: what can we learn from neuroimaging studiesKenneth Marek, Danna Jennings, John Seibyl
JAMA Neurology|November 9, 2017
Observations on a 2-Step Approach to Screening for Parkinson Disease-ReplyDanna Jennings, Andrew Siderowf, Kenneth Marek
Seminars in Nuclear Medicine|August 3, 2010
The role of the core imaging laboratory in multicenter trialsJohn Seibyl, Kenneth Marek, I George Zubal
Annals of Neurology|May 5, 2026
From Parkinson's Progression Markers Initiative to Parkinson's Precision Medicine Initiative: Still PPMIKenneth Marek, Sohini Chowdhury, Thomas F Tropea, et al.
Seminars in Nuclear Medicine|October 3, 2012
Neuroimaging over the course of Parkinson's disease: from early detection of the at-risk patient to improving pharmacotherapy of later-stage diseaseJohn Seibyl, David Russell, Danna Jennings, et al.
Pageof 15